TrialAmerican journal of clinical dermatology2026

Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials.

Brian S Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.